IPI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPI, covering 2020-01-31 to 2020-01-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 [Phase 2]